Registration - Amendment

DALRYMPLE & ASSOCIATES, LLC for PULMATRIX, INC.

Firm
Client
Income
—
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Appropriations and government contracts for development of new therapeutics for prevention, prophylaxis, treatment and transmission of respiratory infectious diseases

LobbyistCovered position, as disclosed
DONALD DALRYMPLE New Principal and Managing Director

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.